AOP Orphan Pharmaceuticals AG
- B01 - Agentes antitrombóticos
- TREPULMIX solution for infusion 1 mg/ml
- TREPULMIX solution for infusion 10 mg/ml
- TREPULMIX solution for infusion 2.5 mg/ml
- TREPULMIX solution for infusion 5 mg/ml
- C07 - Betabloqueantes
- ESMOLOL HYDROCHLORIDE AOP powder for solution for infusion 2 500 mg
- ESMOLOL HYDROCHLORIDE AOP solution for injection 100 mg/10 ml
- H01 - Hormonas hipofisiarias, hipotalámicas y análogos
- ARGIPRESSIN AOP solution for injection 20 IU/ml
- L01 - Antineoplásicos
- ANAGRELIDE AOP capsule, hard 0.5 mg
- L03 - Inmunoestimulantes
- BESREMI PREFILLED PEN solution for injection 250 µg/0.5 ml
- N07 - Otros fármacos activos sobre el sistema nervioso
- ADEPEND film-coated tablet 50 mg
- NALTREXONE HYDROCHLORIDE AOP film-coated tablet 50 mg
- TARDIBEN tablet 25 mg
- TETRABENAZINE AOP tablet 25 mg
- V03 - Todos los demás preparados terapéuticos
- NALOXONE AOP solution for injection 0.4 mg/ml